IRIS - Res&Arch Institutional Research Information System - Research & Archive

MASSARI, SERENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.090
NA - Nord America 4.972
EU - Europa 3.056
SA - Sud America 422
Continente sconosciuto - Info sul continente non disponibili 367
AF - Africa 82
OC - Oceania 3
Totale 13.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.751
CN - Cina 2.527
SG - Singapore 1.276
IT - Italia 781
VN - Vietnam 411
RU - Federazione Russa 406
IE - Irlanda 401
HK - Hong Kong 365
SE - Svezia 325
BR - Brasile 320
UA - Ucraina 217
DE - Germania 194
FR - Francia 149
FI - Finlandia 129
GB - Regno Unito 121
CA - Canada 95
KR - Corea 89
BE - Belgio 74
IN - India 69
BD - Bangladesh 64
PL - Polonia 50
AT - Austria 42
MX - Messico 42
TR - Turchia 42
RO - Romania 35
JP - Giappone 34
NL - Olanda 34
AR - Argentina 31
SA - Arabia Saudita 28
IQ - Iraq 27
PK - Pakistan 27
ES - Italia 25
ID - Indonesia 21
ZA - Sudafrica 21
IL - Israele 20
CO - Colombia 18
UZ - Uzbekistan 17
CZ - Repubblica Ceca 16
EC - Ecuador 16
CH - Svizzera 13
HN - Honduras 12
CI - Costa d'Avorio 11
CL - Cile 11
GT - Guatemala 11
PH - Filippine 11
CR - Costa Rica 10
PR - Porto Rico 10
TT - Trinidad e Tobago 10
VE - Venezuela 10
ET - Etiopia 9
SV - El Salvador 9
EG - Egitto 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
LB - Libano 7
CW - ???statistics.table.value.countryCode.CW??? 6
GR - Grecia 6
LV - Lettonia 6
MY - Malesia 6
PA - Panama 6
PE - Perù 6
EE - Estonia 5
GP - Guadalupe 5
JO - Giordania 5
LT - Lituania 5
SC - Seychelles 5
IR - Iran 4
KE - Kenya 4
NP - Nepal 4
UY - Uruguay 4
AL - Albania 3
AO - Angola 3
DZ - Algeria 3
EU - Europa 3
HR - Croazia 3
KG - Kirghizistan 3
NI - Nicaragua 3
PS - Palestinian Territory 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AM - Armenia 2
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
GE - Georgia 2
HT - Haiti 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LY - Libia 2
NO - Norvegia 2
OM - Oman 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
Totale 13.614
Salva come PNG Salva come JPEG
Città #
Guangzhou 2.081
Singapore 940
Chandler 572
San Jose 493
Perugia 424
Ashburn 411
Dublin 399
Hong Kong 351
Dong Ket 243
San Mateo 201
Santa Clara 183
Boardman 152
Council Bluffs 147
Beijing 114
Jacksonville 111
Los Angeles 98
Moscow 97
Lauterbourg 90
Medford 89
Princeton 88
Seoul 85
Altamura 82
Brussels 74
The Dalles 72
Ann Arbor 71
New York 68
Ho Chi Minh City 62
Munich 61
Lawrence 60
Wilmington 60
São Paulo 46
Fremont 44
Andover 41
Piscataway 40
West Jordan 38
Dallas 37
Hanoi 34
Orem 34
Helsinki 33
Vienna 32
Montreal 31
Redmond 31
Tokyo 30
Warsaw 30
Turku 29
Atlanta 27
Phoenix 27
Bucharest 26
Rome 26
Saint Petersburg 25
Buffalo 24
Brooklyn 23
Dearborn 23
North Bergen 22
Norwalk 20
Denver 19
Hefei 18
Ankara 17
Houston 17
Redwood City 17
Chicago 16
Spoleto 16
Dhaka 15
Mexico City 15
Chennai 14
London 14
Toronto 14
Des Moines 13
Johannesburg 12
Manchester 12
Nuremberg 12
Riyadh 12
Secaucus 12
Abidjan 11
Amsterdam 11
Baghdad 11
Bologna 11
Brasília 11
Charlotte 11
Hanover 11
Milan 11
Poplar 11
Seattle 11
Tashkent 11
Naples 10
Philadelphia 10
Porto Alegre 10
San Francisco 10
Woodbridge 10
Columbus 9
Da Nang 9
Izmir 9
Jeddah 9
Shanghai 9
Stockholm 9
Addis Ababa 8
Guatemala City 8
Lappeenranta 8
Mumbai 8
Olomouc 8
Totale 9.282
Salva come PNG Salva come JPEG
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.160
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 348
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 332
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 219
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 197
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 178
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 177
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 168
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 163
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 157
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 154
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 154
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 151
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 149
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 148
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 148
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 147
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 142
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 141
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 138
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 137
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 136
6-Desfluoroquinolones as promising HIV transcription inhibitors 134
In Vitro effects of alternative smoking devices on oral cells: Electronic cigarette and heated tobacco product versus tobacco smoke 132
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 130
Acting on Tat-Mediated Transcription to Achieve a Long Term Control of HIV-1 Latency 127
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 126
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 125
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 125
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 125
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 124
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 124
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 123
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 121
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 120
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 119
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 119
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps. 118
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 117
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 117
A new quinolone derivative with ultra-potent anti-HIV activity. 116
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 116
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 116
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 115
A New Derivative with Ultra-Potent Anti-HIV Activity 114
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 114
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 114
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 113
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 110
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 110
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 109
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 109
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 107
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 105
Small molecole targeting HPV E6 and E7 oncoproteins expression. 105
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 105
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 105
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 104
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 104
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 103
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 102
6-Aminoquinolones targeting HCV NS5B polymerase. 102
TARGETING CDKs TO INHIBIT THE HIV-1 TAT-MEDIATED TRANSCRIPTION 100
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 99
The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication 99
Phospholipidosis effect of drugs by adsorption into lipid monolayers 99
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 99
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15 98
New compounds targeting the rna polymerase of influenza a and b viruses. 97
Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy 95
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives 90
Nuovi 6-DFQ come inibitori della Transattivazione dell’HIV-1 90
Cycloheptathiophene-3-carboxamide derivatives as influenza A virus polymerase inhibitors 90
Structural Investigation of Cycloheptathiophene-3-carboxamide Derivatives Targeting Influenza Virus Polymerase Assembly 90
Biotinylated Tryptophan Catabolites for Target Fishing. 90
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands 90
Compounds for use in the treatment of cancer and inflammatory conditions 89
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate 87
Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity. 87
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 87
Re-evolution of the 2-phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance 86
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 84
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-protein Interaction as a Target for Next-generation Anti-influenza Therapeutics. 84
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity 83
Triazolopyrimidine nuclei: privileged scaffolds for developing antiviral agents with a proper pharmacokinetic profile. 83
Design, Synthesis, and Evaluation of WC5 Analogues as Inhibitors of Human Cytomegalovirus Immediate-Early 2 Protein, a Promising Target for Anti-HCMV Treatment 82
Designed Multiple Ligands (DLMs) as innovative anti-HIV agents 79
Q-raKtion: A Semiautomated KNIME Workflow for Bioactivity Data Points Curation 78
Disegno e sintesi di agenti anti-HIV a duplice attività 76
Nuovi 6-DFQ come inibitori della transattivazione dell’HIV-1. Abstr O15 75
Targeting the HIV Tat-mediated transcriptional machinery: P-TEFb complex inhibitors 74
SMALL MOLECULES TARGETING HPV E6 AND E7 ONCOPROTEINS EXPRESSION 74
Blocking HIV-1 Replication by Targeting the TAT-Hijacked Transcriptional Machinery 73
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 72
From Small to Powerful: The Fragments Universe and its "Chem-Appeal" 70
Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder. 70
Ethyl 1,8-Naphthyridone-3-carboxylates Downregulate Human Papillomavirus-16 (HPV-16) E6 and E7 Oncogenes Expression 69
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo 65
Protein-protein interactions by influenza polymerase subunits as drug targets 63
Studies on anti-HIV Quinolones 62
Totale 13.646
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.383
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022681 0 0 0 0 73 7 24 242 69 35 111 120
2022/20231.588 96 281 19 161 155 151 3 102 514 15 57 34
2023/20242.830 39 116 37 24 14 22 2.246 16 57 57 78 124
2024/20251.852 19 150 65 139 186 108 246 121 305 113 254 146
2025/20263.810 239 245 173 476 506 345 647 216 446 293 154 70
2026/20271.281 85 119 235 751 91 0 0 0 0 0 0 0
Totale 13.992